Importantly, a single-ApoSQ injection leads to the enhanced induction of PPARγ and PTEN mRNA and protein expression and to a reciprocal reduction in phosphorylated Akt, as well as in the mRNA levels of Snai1 and Zeb1, within primary tumor tissue. The gene discussed is AKT1; the disease is neoplasm.